Pmv Pharmaceuticalsincis A Clinical Stage Precision Oncology Company Based In Princetonnew Jerseyfounded In 2013The Company Focuses On Developing Therapies That Target P53 Mutationswhich Are Found In About Half Of All Human Cancerspmv Pharma Aims To Create First In Class P53 Regulators To Improve Cancer Treatment Outcomes The Company S Lead Product Candidate Is Rezatapoptpc14586 A Selective P53 Reactivator Designed For Patients With Metastatic Solid Tumors That Have The Y220C Mutation In The P53 Proteinpmv Pharma Is Also Exploring Pmv 586 101 For Similar Indicationstheir Innovative Approach Involves Correcting The Structure Of Mutant P53 Proteins To Restore Their Tumor Suppressing Functionsdrawing On Decades Of Expertise In P53 Biology With A Team Of Approximately 47 Employeespmv Pharmaceuticals Promotes A Culture Of Bold Thinking And Executionthe Company Actively Engages With The Financial And Healthcare Sectors Through Investor Conferences And Regular Financial Reportingreflecting Its Commitment To Transparency And Growth In The Biotechnology Field
No conferences found for this company.
| Company Name | Pmv Pharmaceuticals Inc |
| Country |
United States
|
| Address | 8 Clarke Dr Suite 3 Cranbury Nj 08512 |
| Telephone | Login to View |
| Login to View |
